Sort by
Search results
FIBRIPHEN 5
Measurement of fibrinogen in plasma. Detection of low fibrinogen concentrations. Detection of elevated fibrinogen concentrations (> 4g/L): In clinical situations associated with inflammation Risk factor for cardiovascular disease and thrombosis Hypofibrinogenemia, mainly associated with severe liver disease, and excessive consumption of fibrinogen (DIC, hyperfibrinolysis). Numerous variants of fibrinogen described, associated to asymptomatic cases, or to cases with bleeding and/or thrombosis.
FIBRIPHEN™ LRT
Clotting method for quantitative determination of fibrinogen (Clauss method)
FII Inhibitor Plasma (1) mild (1-10 BU/ml), frozen
Can be used as a substitute for plasmas from patients that have developed neutralizing antibodies to coagulation factors. For research use only.
FIX Inhibitor Plasma (1) mild (1-10 BU/ml), frozen
Can be used as a substitute for plasmas from patients that have developed neutralizing antibodies to coagulation factors. For research use only.
FIX Inhibitor Plasma (1) mild (1-10 BU/ml), lyophilized
Can be used as a substitute for plasmas from patients that have developed neutralizing antibodies to coagulation factors. For research use only.
FIXa Calibrator
Lyophilized plasma for the calibration of factor IXa measurements using the chromogenic assays and especially BIOPHEN Factor IXa assay (ref. 221812).
FIXa Controls (ultra low)
Factor IXa controls are intended for the quality control of activated factor IX (FIXa) chromogenic measurements (approx. 1.3 mlU/mL), using BIOPHEN ® Factor IXa assay (ref. 221812).
FIXa Controls (ultra low)
Factor IXa controls are intended for the quality control of activated factor IX (FIXa) chromogenic measurements (approx. 0.2 mIU/mL), using BIOPHEN Factor IXa assay (ref. 221812).
FPA Control - ELISA
Quality control of FPA assay (RK016A).
FPA anticoagulant solution
Blood collection for FPA testing.